INDANE INHIBITORS OF EED AND METHODS OF THEIR USE
Abstract:
Compounds having a structure of Formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein A1, A2, A3, A4, A5, n, and m are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various EED-related conditions or diseases, including cancer, by administration of such compounds are also provided.
Public/Granted literature
Information query
Patent Agency Ranking
0/0